Susan G. Komen for the Cure® Tissue Bank at the IU Simon Cancer Center
The goals of the Susan G. Komen for the Cure® Tissue Bank Tissue Bank at the IU Simon Cancer Center are to acquire biomolecule and tissue specimens from the entire continuum of breast development: puberty to menopause and to make these specimens or the digital data derived from them available and accessible to researchers across the globe. To read more about this work, click here.
We are pleased to collaborate with ASCO, the American Society of Clinical Oncology, focusing on three major programs:
- The Research Initiative - an extramural grants initiative to support research and projects related to the quality of, access to and delivery of cancer care with general applicability in the breast cancer arena
- The Quality of Care Initiative, through which Susan G. Komen for the Cure will provide funding to support TACF/ASCO in its work on quality of cancer care, including workforce issues, with general applicability in the breast cancer arena
- An annual Breast Cancer Symposium through 2010 - sponsored by ASCO and co-sponsored by other organizations with Komen for the Cure serving as Primary Supporter.
We are collaborating with AACR, the American Association for Cancer Research . Since 2007, Komen has granted the AACR close to $6M in conference support and educational programming. Specific programming includes scientific educational sessions, scientific travel scholarships, Scientist Survivor Program and outstanding investigator awards. Following are examples of the meetings:Finding ways to prevent cancer
AACR Annual Meeting
CTRC-AACR San Antonio Breast Cancer Symposium
AACR Disparities Research Meeting
AACR Prevention Research Meeting
AACR Breast Cancer Research Meeting
Translational Breast Cancer Research Consortium
The Translational Breast Cancer Research Consortium (TBCRC) is a collaborative group founded in 2005 to conduct innovative and high-impact clinical trials for breast cancer. The TBCRC consists of 16 research centers, with member personnel representing clinicians, basic scientists, statisticians, and patient advocates. TBCRC trials not only test novel, laboratory-based strategies, but also attempt to understand the underlying cause and biology of breast cancer. Most, if not all, of the TBCRC trials have a specimen submission or tissue banking component. Susan G. Komen for the Cure® is proud to have sponsored the TBCRC since 2007.
World Health Organization
World Health Organization (WHO), Erasmus University Rotterdam (Erasmus) and Radboud University Nijmegen Medical Center (RUNMC), together with funding from Susan G. Komen for the Cure®, can assist developing countries in planning or further improving their breast cancer control programs to make them more effective and efficient in preventing breast cancer, reducing mortality and improving quality of life.
Over the next five years, this initiative will roll out in 10 countries: Ghana, Costa Rica, Mexico, Jordan, Philippines, China, Brazil, Colombia, India and Peru.